Supriya Lifescience Limited — Regulatory Filings 2023

Nov 8, 2023

Date: November 8, 2023

To,	To,
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers	Exchange Plaza, C-1, Block G
Dalal Street,	Bandra Kurla Complex
Mumbai – 400 001	Bandra (E), Mumbai – 400 051
Scrip Code: 543434	Scrip Symbol: SUPRIYA

Dear Sir/Madam,

Subject: Monitoring Agency Report for the Quarter ended September 30, 2023

Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith Monitoring Agency Report issued by ICICI Bank Limited for the quarter ended September 30, 2023 in respect of utilization of proceeds of the of the fresh issue of the IPO of the Company.

Kindly take the same on record and acknowledge the receipt.

Thanking you,

For Supriya Lifescience Limited

SHWETA SHIVDHARI SINGH

Digitally signed by SHWETA SHIVDHARI SINGH Date: 2023.11.08 17:35:34 +05'30'

Shweta Singh Company Secretary & Compliance Officer Membership No.: A44973

Corporate office	: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India.
	Tel: +91 22 40332727 / 66942507		Fax : +91 22 26860011	GSTIN: 27AALCS8686A1ZX
				CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
				: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India.
Factory

GOVT. RECOGNISED EXPORT HOUSE

Report of the Monitoring Agency

Name of the Issuer: : Supriya Lifescience Limited For quarter ended: Sept 30, 2023 Name of the Monitoring Agency: ICICI Bank Limited

a) Deviation from the objects: No deviation from the object

(b) Range of Deviation*: Not applicable

Declaration:

We declare that this report is based on the format prescribed by the SEBI (ICDR) Regulations, 2018, We further declare that this report provides a true and fair view of the utilization of the issue proceeds.

We declare that we do not have any direct/indirect interest in or relationship with the issuer/promoters/ directors/management and also confirm that we do not perceive any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer.

Signature:

Nam@of the Authorized Person/Signing Authority: Narasimha Nayak Designation of Authorized person/Signing Authority: Zonal Head Seal of the Monitoring Agency: Date: 8" Nov 2023

ICICI Bank Limited Tel.: (91-22) 2653 1414 ICICI Bank Tower, ICICI Bank Towers Fax: (91-22) 2653 1122 Near Chakli Circle, Bandra-Kurla Complex Website www. icicibank.com Old Padra Rd, Mumbai 400 051, India CIN.: L65190GJ1994PLC021012 Vadodara 390 007, India

Regd. Office:

1) Issuer Details: Name of the issuer: Supriya Lifescience Limited
Names of the promoter: Satish Waman Wagh Industry/sector to which it belongs: Manufacturer of Active pharmaceutical Ingredients.
2) Issue Details: Issue Period: 16 December 2021 to 20 December, 2021
Type of issue (public/rights): Public Issue Equity Shares 'Type of specified securities:
Preferential Issue Grading, if any: NA Issue size (in Million): Equity Shares of Rs.7000.00 Million
3) Details of the arrangement made to ensure the monitoring of issue proceeds: [(Give item by item description for all the objects, as well as for the sub-heads (if any) given under objects, stated in the offer
document separately in following format)] Particulars	Reply	Source of	Comments of the Comments of the
		information / certifications considered by Monitoring Agency for preparation of report	Monitoring Agency	Board of Directors
Whether all utilization is as per the disclosures in the Offer Document?	Yes/No	Certificate provided by Statutory Auditor	Yes	Yes
Whether shareholder approval has been obtained in case of Yes/No material deviations* from expenditures disclosed in the Offer		NA	NA	NA
Document? Whether the means of finance for the disclosed objects of the issue has changed?	Yes/No	NA	No	No
Is there any major deviation observed over the earlier monitoring agency reports?	Yes/No	NA	No	No
Whether all Government/statutory approvals related to the object(s) have been obtained?	Yes/No	Declaration provided NA by the company		NA
Whether all arrangements pertaining to technical assistance/collaboration are in operation?	Yes/No	NA	NA	NA
Are there any favorable events improving the viability of these object(s)?	Yes/No	NA	NA	NA
Are there any unfavorable events affecting the viability of the object(s)?	Yes/No	NA NA	No No	No No
Is there any other relevant information that may materially affect the decision making of the investors?	Yes/No
*Where material deviation may be defined to mean:
a) Deviation in the objects or purposes for which the funds have been raised b) Deviation in the amount of fund actually utilized by more than 10% of the amount projected in the offer documents. NA
4) Details of object(s)s to be monitored:

4) Details of object(s)s to be monitored:

Bandra-Kurla Complex Mumbai 400 051, India

ICICI Bank Limited Tel.: (91-22) 2653 1414 ICICI Bank Tower, ICICI Bank Towers Fax: (91-22) 2653 1122 Near Chakli Circle, Website www.icicibank.com CIN.: L65190GJ1994PLC021012

Regd. Office: Old Padra Rd, Vadodara 390 007, India

(i Cost of object(s)- INR in Million

(i Sr.	Cost of object(s)- INR in Million Item Head		Source of information/ Original
		certifications
		considered by	Monitoring Agency for Document)	Cost (as per Offer	Cost	of Agency		Revised Comments Comments of Board of Directors Reason Proposed Particulars of Monitoring of cost financing firm revision option	'arrangements
	Funding Capital Expenditure	preparation of report Statutory Auditor Certificate and		923.00	NA	No Comments	Not Applicable		made
	Requirements Repayment/Pre- Statutory Auditor payment of	Company Declaration Certificate and		600.00	NA	No Comments	Not Applicable
	borrowing General Corporate	Company Declaration Statutory Auditor Certificate and		359.52	379.99* No	Comments	Not Applicable
	Purpose Total	Company Declaration		1882.52	NA
	* Note - *On finalization of offer expenses, the amount proposed to be utilized for General Corporate Purposes is revised to INR. 379.99 million as compared to original amount of INR. 359.52 million.
	Progress in the object(s)- INR in Million
(ii)

No	Sr. Item Head	certifications considered by	Source of information/ Original Monitoring Agency for Document)	Cost (as per Offer	Cost	of Agency		Revised Comments Comments of Board of Directors Reason Proposed Particulars of Monitoring of cost financing firm revision option	'arrangements
1	Funding Capital Expenditure Requirements		preparation of report Statutory Auditor Certificate and Company Declaration		NA	No Comments		made Not Applicable
2	payment of borrowing	Repayment/Pre- Statutory Auditor Certificate and Company Declaration				600.00	NA	No Comments	Not Applicable
3	General Corporate Purpose	Statutory Auditor Certificate and Company Declaration		359.52	379.99* No	Comments		Not Applicable
	Total			1882.52	NA
No	Sr. ] _ Item Head	Source of information/ proposed in certifications	Amount as Offer		'Amount utilized		Total] unutilized	Comments Comments of Amount Monitoring		of Board of Directors
		considered Document		Asat	During	Atthe		'Agency Reason Proposed
1	Funding	by Monitoring 'Agency for preparation of report Statutory	923.00	Beginning ofthe quarter	the quarter	endof the quarter 299.07 19473 49380	429.20	No	funds No Idle	NA
	Capital Expenditure ; Requirements Declaration	Auditor Seriiicote mpany						Comments	Funds
2	Repayment' Pre-payment Auditor	Statutory of borrowing Certificate and Company Declaration	600.00	600.00		00.00 600.00	00.00	No Comments	No Idle Funds	NA
3	General __ Statutory Corporate _ Auditor Purpose _ Certificate	and Company Declaration	379.99	35095		1000 36095	19.04	No Comments	No idle Funds	of idle Course of Action NA

ICICI Bank Limited ICICI Bank Towers Bandra-Kurla Complex Mumbai 400 051, India Tel.: (91-22) 2653 141 ⁴ Fax: (91-22) 2653 1122 Website www.icicibank.com CIN.: L65190GJ1994PLC021012

Regd. Office: ICICI Bank Tower, Near Chakli Circle, Old Padra Rd, Vadodara 390 007, India

			(ii), Deployment of unutilized Public Offer proceeds- INR in Million
Sr. No			Type of instrument and name of the entity invested in ] Amount		invested date	Maturity	0"	Earnings Returnon (%)	Market Value Investment as at the end of quarter
1		Fixed Deposit with ICICI Bank			35.00	07/01/2025	5.33	7.15%	NA
2		Fixed Deposit with ICICI Bank			450.00 15.51	14/04/2024 34.33 NA.	NA.	7.25% NA.	NA NA
3	Total	ICICI Bank Monitoring Account			500.51**		39.66
	(iv) Delay in	implementation of the object(s)-	Note:- ** Amount Invested showing higher than amount unutilized due to interest earned on FD is included in invested amount.
Saati			Completion Date 2	Delay (No. of days/				Comments of Board of Directors	3

			(ii), Deployment of unutilized Public Offer proceeds- INR in Million
Sr. No			Type of instrument and name of the entity invested in ] Amount			invested date	Maturity		Earnings Returnon 0"			Market Value Investment as at the end
1		Fixed Deposit with ICICI Bank			35.00			07/01/2025	5.33	(%) 7.15%		of quarter NA
2		Fixed Deposit with ICICI Bank			450.00	15.51	NA.	14/04/2024 34.33	NA.	7.25% NA.		NA NA
3		ICICI Bank Monitoring Account
	Saati Name	As per Offer ersOts	Completion Date 2 Actual		Comments of Board of Directors Delay (No. of days/ Reason of delay Rede) Due to Change in scope of work, Approx 9-12 designing of equipment got changes					3 Proposed Course of Action
	SABES	net	Nat * in case of continuing object(s) please specify latest/revised estimate of completion date	Months				which leads to delay in implementation				In FY 23-24 the same will be implemented.
			5) Details of utilization of proceeds stated as General Corporate						Purpose (GCP) amount in the offer document:	Million)
Sr. ]	Item Head		'Amount as	Amount utilized						Total unutilized Amount
No			proposed in Offer	As at Beginning of		Duringthe quarter		Atthe end of the
1	Purpose#	General Corporate	Document 379.99"	the quarter 350.00		10.00		quarter 360.95			19.04
* Note - On Signature;		'compared to original amount of INR. 359.52 million. # Utilisation of Funds for Vendor payments.										finalization of offer expenses, the amount proposed to be utilized for General Corporate Purposes is revised to INR. 379.99 million as
Date: 8	Nov 2023	Seal of the Monitoring Agency:	Name of the Authorized Person/Signing Authority: Narasimha Nayak Designation of Authorized person/Signing Authority: Zonal Head

Sr.	] Item Head	'Amount as	Amount utilized			Total unutilized Amount
No		proposed in Offer Document	As at Beginning of the quarter	Duringthe quarter	Atthe end of the quarter
1	General Corporate Purpose#	379.99"	350.00	10.00	360.95	19.04

Signature;

ICICI Bank Limited ICICI Bank Towers Bandra-Kurla Complex Mumbai 400 051, India

: (91-22) 2653 14 14 Fax: (91-22) 2653 1122 Website www. ici ink.com CIN.: L65190GJ1994PLC021012 Regd. Office: ICICI Bank Tower, Near Chakli Circle, Old Padra Rd, Vadodara 390 007 |, India